A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital de la Princesa-UAM in Madrid have discovered that dendritic cells, an important cell type in the immune response to viral ...
Nov 3, 2023
0
15
Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics. That makes it notoriously difficult to treat, but ...
Oct 31, 2023
0
28
Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why. Their findings were published today in PLOS Pathogens.
Oct 26, 2023
0
31
Clostridioides difficile (C. diff) intestinal infections can cause severe, debilitating diarrhea in patients who are hospitalized or on immunosuppressive therapies. The infections can be very hard to eradicate, roaring back ...
Oct 26, 2023
0
21
A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body's immune response to target cancer cells.
Oct 26, 2023
0
26
The parasitic disease leishmaniasis is found primarily in Central and South America, the Mediterranean region, the Middle East, and Central Asia and is transmitted to humans by a sand fly. An estimated 1.5 million new cases ...
Oct 24, 2023
0
16
Mayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatment for triple-negative breast cancer. The multi-omics study, published in Breast ...
Oct 23, 2023
0
16
Combining immunotherapy with radiation could be a promising treatment option for patients with advanced soft tissue sarcoma, according to the results of a clinical trial led by Northwestern Medicine investigators published ...
Oct 20, 2023
0
41
A team of UC Davis scientists has used dynamic total-body positron emission tomography (PET) to provide the first imaging of the human body's immune response to COVID-19 infection in recovering patients. Their work, published ...
Oct 19, 2023
0
19
A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial ...
Oct 19, 2023
0
84
